The company that makes one of the two most widely used brands of formula for premature babies is threatening to stop. That is, unless US health officials and Congress help protect it from lawsuits related to infant deaths allegedly tied to its product.
It’s a warning that holds particular power over policy makers and legislators who’ve become acutely aware of the
At the heart of the lawsuits ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.